跳至主要内容
临床试验/IRCT20200506047323N2
IRCT20200506047323N2招募中3 期

Evaluation of the effects of Licorice on clinical symptoms and laboratory signs in patients with COVID-19: An open-label randomized clinical trial

Bandare-abbas University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age =18 years
  • Positive polymerase chain reaction (PCR) test for COVID-19 or/and lung involvement in imaging
  • Primary clinical symptoms
  • Hospitalized
  • Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm

排除标准

  • Underlying diseases (heart disease, chronic hypertension, severe renal failure, severe liver failure, and thyroid disorders)
  • Use of warfarin, SSRIs, MAOIs, diuretics, corticosteroids, and antiarrhythmic drugs
  • History of drug allergy
  • Pregnancy and breastfeeding

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验